a Phase 1b/2a Study of JMT202 Injection in Participants With Hypertriglyceridemia

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
a Phase 1b/2a Study of JMT202 Injection in Participants With Hypertriglyceridemia	Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, hypertriglyceridemia, metabolic disease	Recruiting	Phase 1 / Phase 2	2025-12-30		NCT07140809

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Shanghai JMT-Bio Inc.	30

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Hospital of Peking University	Beijing	China	1

Clinical trials